Abstract
Purpose
To study right-angled vessels (RAV) in disease progression and macular neovascularization in type 2 macular telangiectasia (MacTel) eyes.
Methods
This retrospective image analysis study examined type 2 MacTel patients’ multicolour® and OCT imaging records from January 2015 to March 2023. Age, gender, laterality, visual acuity, systemic disease, and follow-up duration were recorded. RAV characteristics were assessed using OCT and multicolour® images. This study examined RAV characteristics and type 2 MacTel disease stage.
Results
In total, 270 eyes of 146 patients (97 females, 66%) with a mean age of 60.77 ± 9.34 years were studied. 153 (57%) eyes showed RAV. The non-proliferative stage of type 2 MacTel had either no RAV or a normal-calibre right-angled vein, while the proliferative stage had a right-angled artery and a dilated or normal-calibre RAV [p < 0.001]. RAV characteristics differed at the final follow-up (p < 0.001). 11 eyes transitioned from non-proliferative to proliferative after a median period of 26 months (range: 5–96 months). RAV characteristics changed from a normal calibre right-angled vein at presentation to a normal calibre vein and artery in 6 (55%) eyes and to a dilated vein and artery in 5 (45%) eyes respectively.
Conclusion
RAV characteristics may indicate type 2 MacTel stages. A right-angled artery in type 2 MacTel may indicate proliferative disease.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 18 print issues and online access
$259.00 per year
only $14.39 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Data availability
The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.
References
Charbel Issa P, Gillies MC, Chew EY, Bird AC, Heeren TFC, Peto T, et al. Macular telangiectasia type 2. Prog Retin Eye Res 2013;34:49–77.
Gass JD, Blodi BA. Idiopathic juxtafoveolar retinal telangiectasis. Update classification follow- study. Ophthalmol. 1993;100:1536–46.
Yannuzzi LA, Bardal AMC, Freund KB, Chen K-J, Eandi CM, Blodi B. Idiopathic macular telangiectasia. Arch Ophthalmol Chic Ill 1960. 2006;124:450–60.
Heeren TFC, Clemons T, Scholl HPN, Bird AC, Holz FG, Charbel Issa P. Progression of vision loss in macular telangiectasia type 2. Investig Opthalmol Vis Sci 2015;56:3905.
Heeren TFC, Chew EY, Clemons T, Fruttiger M, Balaskas K, Schwartz R, et al. Macular telangiectasia type 2: visual acuity, disease end stage, and the MacTel area: MacTel project report number 8. Ophthalmology. 2020;127:1539–48.
Tzaridis S, Heeren T, Mai C, Thiele S, Holz FG, Charbel Issa P, et al. Right-angled vessels in macular telangiectasia type 2. Br J Ophthalmol. 2019: bjophthalmol-2018-313364.
Charbel Issa P, Berendschot TTJM, Staurenghi G, Holz FG, Scholl HPN. Confocal blue reflectance imaging in type 2 idiopathic macular telangiectasia. Invest Ophthalmol Vis Sci 2008;49:1172–7.
Charbel Issa P, Finger RP, Helb H-M, Holz FG, Scholl HPN. A new diagnostic approach in patients with type 2 macular telangiectasia: confocal reflectance imaging. Acta Ophthalmol. 2008;86:464–5.
Venkatesh R, Pereira A, Bavaharan B, Jain K, Aseem A, Sangai S, et al. Relevance of multicolor imaging in type 2 macular telangiectasia. J Curr Ophthalmol 2020;32:375–80.
Garg AK, Knight D, Lando L, Chao DL. Advances in retinal oximetry. Transl Vis Sci Technol. 2021;10:5.
Crane NJ, Schultz ZD, Levin IW. Contrast enhancement for in vivo visible reflectance imaging of tissue oxygenation. Appl Spectrosc. 2007;61:797–803.
Nitzan M, Nitzan I, Arieli Y. The various oximetric techniques used for the evaluation of blood oxygenation. Sensors. 2020;20:4844.
Huang Y, Gangaputra S, Lee KE, Narkar AR, Klein R, Klein BEK, et al. Signal quality assessment of retinal optical coherence tomography images. Invest Ophthalmol Vis Sci. 2012;53:2133–41.
Toto L, Di Antonio L, Mastropasqua R, Mattei PA, Carpineto P, Borrelli E, et al. Multimodal imaging of macular telangiectasia type 2: focus on vascular changes using optical coherence tomography angiography. Investig Opthalmology Vis Sci. 2016;57:OCT268.
Govindahari V, Fraser-Bell S, Ayachit AG, Invernizzi A, Nair U, Nair DV, et al. Multicolor imaging in macular telangiectasia—a comparison with fundus autofluorescence. Graefes Arch Clin Exp Ophthalmol. 2020;258:2379–87.
Wu L. Multimodality imaging in macular telangiectasia 2: a clue to its pathogenesis. Indian J Ophthalmol. 2015;63:394.
Powner MB, Gillies MC, Zhu M, Vevis K, Hunyor AP, Fruttiger M. Loss of Müller’s cells and photoreceptors in macular telangiectasia type 2. Ophthalmology. 2013;120:2344–52.
Srinivasan R, Teussink MM, Sloan KR, Bharat RPK, Narayanan R, Raman R. Distribution of macular pigments in macular telangiectasia type 2 and correlation with optical coherence tomography characteristics and visual acuity. BMC Ophthalmol. 2022;22:264.
Venkatesh R, Reddy NG, Mishra P, Agrawal S, Mutalik D, Yadav NK, et al. Spectral domain OCT features in type 2 macular telangiectasia (type 2 MacTel): its relevance with clinical staging and visual acuity. Int J Retin Vitr. 2022;8:26.
Reddy NG, Venkatesh R, Jayadev C, Agrawal S, Yadav NK, Chhablani J. Direct laser photocoagulation to the dilated right-angled vessel in the management of proliferative type 2 macular telangiectasia. Retin Cases Brief Rep. 2023;17:620–4.
Author information
Authors and Affiliations
Contributions
RV, JC, VP—conceptualising the study, data acquisition, analysing the data, statistics and results, interpreting the findings, writing & reviewing the manuscript. AC, AH, SPC, ISA, RB—Data acquisition and analysing the data. NKY—critically reviewing the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Venkatesh, R., Handa, A., Chitturi, S.P. et al. Right-angled vessel characteristics in different stages of type 2 macular telangiectasia (MacTel). Eye 38, 1162–1167 (2024). https://doi.org/10.1038/s41433-023-02853-w
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41433-023-02853-w